These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9543144)

  • 1. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
    Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
    Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
    Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
    Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
    J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.
    Agretti P; Dimida A; De Marco G; Ferrarini E; Rodrìguez Gonzàlez JC; Santini F; Vitti P; Pinchera A; Tonacchera M
    J Endocrinol Invest; 2011 Mar; 34(3):170-4. PubMed ID: 20479570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
    Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter.
    Tonacchera M; Pinchera A; Dimida A; Ferrarini E; Agretti P; Vitti P; Santini F; Crump K; Gibbs J
    Thyroid; 2004 Dec; 14(12):1012-9. PubMed ID: 15650353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the sodium iodide symporter in human kidney.
    Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
    Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.
    Fierabracci P; Pinchera A; Tonacchera M; Agretti P; De Marco G; Albertini S; Conforti G; Seregni E; Agresti R; Grasso L; Giani C
    J Endocrinol Invest; 2004 Oct; 27(9):862-5. PubMed ID: 15648551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and tissue distribution of the human sodium iodide symporter gene.
    Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
    Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a Chinese hamster ovary cell line, CHO-4J, stably expressing a number of Na+/I- symporters.
    Kosugi S; Sasaki N; Hai N; Sugawa H; Aoki N; Shigemasa C; Mori T; Yoshida A
    Biochem Biophys Res Commun; 1996 Oct; 227(1):94-101. PubMed ID: 8858109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibody against Na+/I- symporter (NaIS)].
    Zeki K
    Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
    Muller I; Zhang L; Giani C; Dayan CM; Ludgate ME; Grennan-Jones F
    J Endocrinol Invest; 2016 Mar; 39(3):323-31. PubMed ID: 26253711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.
    Endo T; Kaneshige M; Nakazato M; Kogai T; Saito T; Onaya T
    Biochem Biophys Res Commun; 1996 Nov; 228(1):199-202. PubMed ID: 8912659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
    J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro.
    Josefsson M; Evilevitch L; Weström B; Grunditz T; Ekblad E
    Exp Biol Med (Maywood); 2006 Mar; 231(3):277-81. PubMed ID: 16514173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
    Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
    Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different electrophysiological character of I-, ClO4-, and SCN- in the transport by Na+/I- symporter.
    Yoshida A; Sasaki N; Mori A; Taniguchi S; Mitani Y; Ueta Y; Hattori K; Sato R; Hisatome I; Mori T; Shigemasa C; Kosugi S
    Biochem Biophys Res Commun; 1997 Feb; 231(3):731-4. PubMed ID: 9070882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.